Degenerative diseases of the nervous system in children are acknowledged to be chronic (usually) and destructive (invariably), and for the biochemically oriented clinician they provide a challenging interest because most are genetically, and probably, therefore, chemically determined. Individually relatively rare, most of them are inherited as autosomal recessive conditions, and by implication may represent the clinical effects of inborn metabolic errors. Nevertheless only a minority at present are thus identified because, except where there is an easily recognizable storage product such as ganglioside, or abnormal metabolic cumulation readily identifiable in body fluids such as amino acid, it is usually very difficult to guide biochemical research on purely clinical and pathological indications. It is still necessary and possible, however, to give an accurate prognosis and genetic analysis without any biochemical information, but biochemical refinements offer the opportunity of delineating syndromes which at a given point in time are clinically indistinguishable, e.g. Tay-Sachs variants, and this may be important in genetic counselling.
In a few conditions biochemical identification of fetal tissues enables a more constructive opportunity for eugenic measures. At the present stage of our knowledge, and with perennial economic limitations on screening measures, a discriminating use of elaborate biochemical techniques is desirable and it is proposed to review a scheme of investigation which depends for its usefulness upon a careful clinical appraisal, and therefore is applicable to conditions which are not identifiable chemically as well as those that are.
Abroad neuropathological classification of heredodegenerative neurological diseases is presented in Table I . Marrow examination provides an extension of haematological studies especially valuable where there is a reticuloendothelial involvement. It may provide diagnostically significant material in, for example, Gaucher's disease, generalized GM1 gangliosidosis, and in 'sea blue histiocyte' disease (Lake, Stephens, and Neville, 1970) . As a source of culture material for histochemical study it is rivalled by skin biopsy (see later).
Radiology. Diagnostically helpful radiological abnormalities of long bones and/or spine are seen in a variety of conditions where both marrow and matrix as well as epiphysial plate may be involved, e.g. the mucopolysaccharidoses, Gaucher's disease, mucolipidoses (Spranger and Wiedemann, 1970) , homocystinuria, and the gangliosidoses.
Skull radiology can be most informative. Of outstanding positive diagnostic value is the phenomenon described by Pampiglione (1961) and now validated in over a score of histologically proven cases of one of the late infantile forms of amaurotic family idiocy. It comprises an abnormal response to photic stimulation at low rates of flicker, with repetitive discharges at an idiosyncratic frequency independent of the higher flicker rates. This pathognomonic 'sign' has recently been 'rediscovered' (Green, 1971) .
For departments with appropriate apparatus there is a computerized averaging technique for measuring cortically evoked responses to both auditory and visual stimuli. In the case of the latter the study of visually evoked responses in the occipital cortex is of special value in some of the degenerative diseases which specially affect optic radiations or occipital cortex, e.g. diffuse scleroses.
The study of visual pathways can be further clarified by measurement of the electroretinogram potentials, with an electrode placed on the bridge of the nose or on the corneal conjunctiva (Harden and Pampiglione, 1970) . The electroretinogram response is diminished or absent in the tapetoretinal degenerations, and can be of particular help in investigation of the amaurotic family idiocies. In these conditions the response is lost at an early stage when ophthalmic signs may not be particularly obvious (Harcourt, 1970 Other biochemical studies are deservedly restricted for conditions where clinical studies and preliminary screening have provided some selection of patients, in particular separating off cases of primary mental subnormality and cerebral palsy.
Likewise, assay of sphingomyelinase andglucocerebrosidase in white blood cells may establish, respectively,the biochemical basis of a diagnosis of Niemann-Pick (Kampine et al., 1967) or Gaucher's disease (Patrick, 1965) . In GM1 gangliosidosis the various forms can be differentiated by white cell assays of the g-galactosidase isoenzymes (R. Ellis, personal communication). Similarly isoenzyme assay of white cell and serum hexosaminidase is of value in differentiating the various forms of Tay-Sachs disease and the other GM2 gangliosidoses.
Although essential for a diagnosis of hepatolenticular degeneration, blood copper and copper oxidase are needlessly included in some neurological screening programmes since it is almost unknown for this condition to manifest itself as a neurological condition before the age of 10 years, though it may present as a haemolytic-hepatitic episode earlier.
The demonstration of an increased phytanic acid concentration in the blood is sufficient to establish a diagnosis of Refsum's disease, while plasma lipoprotein assay is necessary unequivocally to identify a-,B-lipoproteinaemia (Bassen-Komzweig disease) or an a-lipoproteinaemia (Tangier disease), both of which have important neurological components.
Among the heterogeneous leucodystrophies, two main conditions have been separately identified: metachromatic leucodystrophy (late infantile, juvenile, and adult forms) and globoid cell leucodystrophy (Krabbe, or infantile form, and later forms).
Aryl sulphatase determinations in white blood cells and urine may clinch a diagnosis of metachromatic leucodystrophy, already strongly suggested by the clinical picture with evidence of slowing of nerve conduction, and by the demonstration of distinctive intracellular metachromatic material in fresh spun urinary sediment (Lake, 1965) .
In Krabbe's leucodystrophy the enzyme galactocerebroside /-galactosidase is lacking (Austin et al., 1970) , and this deficiency can be shown by an isotopic technique in white blood corpuscles.
Less well-defined biochemically among the diffuse scleroses is a sex-linked recessive form associated with suprarenal insufficiency (Siemerling and Creutzfeldt, 1923) . Though the literature suggests that clinical adrenal insufficiency antedates the neurological disorder (Forsyth, Forbes, and Cumings, 1971) , in my experience in a series of cases selected by their presentation as neurological syndromes (mimicking acute encephalopathies, or acute demyelinating diseases) the only evidence of suprarenal dysfunction has been reduced or absent cortisol production after ACTH stimulation.
Biopsy
Rectal mucosa and appendix. The purpose of a rectal biopsy is to obtain a full-thickness sample containing sufficient ganglion cells to allow histochemical study (Bodian and Lake, 1963) . The staining may show intraneuronal lipid inclusions as in Tay-Sachs disease and the other gangliosidoses, or lipofuscin inclusions in the amaurotic family idiocies. In sulphatide lipidosis (metachromatic leucodystrophy) metachromatically-staining material is seen either lying apparently free, or phagocytosed in the ganglion-cell layer.
Though the histochemical demonstration of increased lysosomal acid phosphatase activity in the ganglion cells is nonspecific, its occurrence in an infant with a suggestive clinical picture makes a diagnosis of Krabbe's leucodystrophy very probable. Ifthe technique of white cell assay of ,B-galactosidase mentioned above is not available, the diagnosis can only be established with certainty by brain biopsy.
A full-thickness biopsy carries with it a higher risk of haemorrhage, sepsis, and technical failure in inexperienced hands than removal of the appendix, and for these reasons the latter is often preferred. Ganglion cells are, however, smaller and abnormal staining correspondingly less impressive in the appendix than in the rectum (Brett and Berry, 1967 (Sloan, 1970) . This is because the metabolic abnormalities underlying many of the neurolipidoses are not restricted only to neuraxial tissue.
Such studies are of interest at present mainly for research purposes, for example in the mucopolysaccharidoses (Wiesmann and Neufeld, 1970) , the mucolipidoses (Spranger and Wiedemann, 1970; Leroy et al., 1971; Tondeur et al., 1971) , TaySachs disease (Schneck et al., 1970) , GM1 gangliosidosis (Sloan et al., 1969) , and metachromatic leucodystrophy (Porter et al., 1970) , but the technique will undoubtedly be of great practical importance.
Enzymological and histochemical studies in cultured tissue is of special value in those conditions in which amniotic cells either normally contain a particular enzyme or accumulate an identifiable storage compound when abnormal. This technique has obvious application in prenatal diagnosis and allows 'positive' genetic counselling in a steadily increasing number of conditions, of which one might quote Tay-Sachs disease (Schneck et al., 1970) and metachromatic leucodystrophy (Porter et al., 1970) .
Peripheral nerve biopsy. Segmental demyelination of peripheral nerves is well recognized in metachromatic leucodystrophy (Fullerton, 1964) and in globoid cell leucodystrophy (Lake, 1968; Dunn et al., 1969) . This may be suspected not only from the clinical picture but also from the slowing of nerve conduction, and a specimen suitable for both histochemical and ultrastructural study can be obtained just behind the lateral malleolus. In metachromatic leucodystrophy the characteristic staining reaction can usually be shown easily if there is evidence of electrical abnormality.
In hypertrophic interstitial neuritis, the distinctive onion-skin appearance will identify the disease before clinical evidence of nerve hypertrophy is discovered, but the condition can be surmised without biopsy in Refsum's disease, if increased phytanic acid concentration is shown in plasma.
In summing up it is acknowledged that, individually, the conditions mentioned here are rare, and even as a group they represent a small minority of the neurological and neuropsychiatric problems in paediatric practice. But since they often present and masquerade as more benign conditions such as cerebral palsy or epilepsy, the paediatrician's perturbation about not missing a sinister disease may tempt him into the indiscriminate use of procedures that are unnecessary. From the array of biochemical abnormalities now identified and the welter of laboratory studies available, the clinician may be forgiven some bewilderment. It is suggested that the use of both potentially harmful as well as complex and expensive investigations must be concentrated in appropriately equipped and specialized units.
